IRIS (R) Mol. Diagnostics platform for AMR
A novel diagnostics platform for customized molecular diagnostics for AMR.
The only product specifically designed for the needs of Latin America hospitals, for screening of AMR genes and Candida among hospitalized patients (adults, children and neonates)
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Validation
- Research
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- Joint Venture
- License
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- BSI
- GII
- UTI
- STI
- RTI
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- South America
- North America
- Eurasia
- Africa
- Oceania
Interested in non-refundable funds and smart investment from Venture Capital funds, NGOs or individuals.
Biotechnology company with proprietary molecular diagnostics platform, focused on customized AMR diagnostics.
Custom made diagnostic kits for Pharmacogenomics
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!